An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Hearing loss in adults: assessment and management.
National Guideline Centre (UK).
London: National Institute for Health and Care Excellence (NICE); 2018 Jun. (NICE Guideline, No. 98.)
Top results in this bookTable of Contents
Challenging Behaviour and Learning Disabilities: Prevention and Interventions for People with Learning Disabilities Whose Behaviour Challenges.
National Collaborating Centre for Mental Health (UK).
London: National Institute for Health and Care Excellence (NICE); 2015 May. (NICE Guideline, No. 11.)
Mental Health Problems in People with Learning Disabilities: Prevention, Assessment and Management.
National Guideline Alliance (UK).
London: National Institute for Health and Care Excellence (NICE); 2016 Sep. (NICE Guideline, No. 54.)
Suspected neurological conditions: recognition and referral.
London: National Institute for Health and Care Excellence (NICE); 2019 May. (NICE Guideline, No. 127.)
Sickle Cell Acute Painful Episode: Management of an Acute Painful Sickle Cell Episode in Hospital.
Manchester (UK): National Institute for Health and Clinical Excellence (NICE); 2012 Jun. (NICE Clinical Guidelines, No. 143.)
Managing Chronic Pain in Adults With or in Recovery From Substance Use Disorders.
Center for Substance Abuse Treatment.
Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2012. (Treatment Improvement Protocol (TIP) Series, No. 54.)
Guidelines on Neonatal Seizures.
Geneva: World Health Organization; 2011.
Guidelines on the management of chronic pain in children.
Geneva: World Health Organization; 2020.
Universal Newborn Hearing Screening: Systematic Review to Update the 2001 U.S. Preventive Services Task Force Recommendation [Internet].
Nelson HD, Bougatsos C, Nygren P.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2008 Jul. (Evidence Syntheses, No. 62.)
PDQ Cancer Information Summaries [Internet].
Bethesda (MD): National Cancer Institute (US); 2002-.
Urinary Incontinence in Neurological Disease: Management of Lower Urinary Tract Dysfunction in Neurological Disease.
National Clinical Guideline Centre (UK).
London: Royal College of Physicians (UK); 2012 Aug. (NICE Clinical Guidelines, No. 148.)
Varicose Veins in the Legs: The Diagnosis and Management of Varicose Veins.
London: National Institute for Health and Care Excellence (NICE); 2013 Jul. (NICE Clinical Guidelines, No. 168.)
Addendum to Psychosis and schizophrenia in children and young people.
London: National Institute for Health and Care Excellence (NICE); 2016 May. (Clinical Guideline Addendum, No. 155.1.)
Cerebral palsy in under 25s: assessment and management.
London: National Institute for Health and Care Excellence (NICE); 2017 Jan. (NICE Guideline, No. 62.)
CADTH Canadian Drug Expert Committee Recommendation: AbobotulinumtoxinA (Dysport Therapeutic — Ipsen Biopharmaceuticals Canada Inc.): Indication: For the symptomatic treatment of lower limb spasticity (LLS) in pediatric patients two years of age and older [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Aug.
Pharmacological Interventions for Chronic Pain in Pediatric Patients: A Review of Guidelines [Internet].
Banerjee S, Butcher R.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 May 5.
Faecal Incontinence: The Management of Faecal Incontinence in Adults.
London: National Collaborating Centre for Acute Care (UK); 2007. (NICE Clinical Guidelines, No. 49.)
Obsessive-Compulsive Disorder: Core Interventions in the Treatment of Obsessive-Compulsive Disorder and Body Dysmorphic Disorder.
Leicester (UK): British Psychological Society (UK); 2006. (NICE Clinical Guidelines, No. 31.)
CADTH Canadian Drug Expert Committee Recommendation: Voretigene Neparvovec (Luxturna — Novartis Pharmaceuticals Canada Inc.): Indication: Vision loss, inherited retinal dystrophy [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Nov.
CADTH Canadian Drug Expert Committee Recommendation: AbobotulinumtoxinA (Dysport Therapeutic — Ipsen Biopharmaceuticals Canada Inc.): Indication: For the symptomatic treatment of focal spasticity affecting the upper limbs in adults [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Oct.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on